Edwards Lifesciences Corporation Other Comprehensive Income (Loss), Derivatives Qualifying as Hedges, Net of Tax
Edwards Lifesciences Corporation (EW) reported Other Comprehensive Income (Loss), Derivatives Qualifying as Hedges, Net of Tax of -$12.60 million for the 3-month period ending 2018-03-31, per its 10-Q filed 2018-04-27.
Discontinued › Income Statement › Unrealized Gains
us-gaap:OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax · last filed 2018-04-27
- Edwards Lifesciences Corporation other comprehensive income (loss), derivatives qualifying as hedges, net of tax for the quarter ending 2018-03-31 was -$12.60M.
- Edwards Lifesciences Corporation other comprehensive income (loss), derivatives qualifying as hedges, net of tax for the quarter ending 2017-12-31 was -$1.40M, a 105.05% decline year-over-year.
- Edwards Lifesciences Corporation other comprehensive income (loss), derivatives qualifying as hedges, net of tax for the quarter ending 2017-09-30 was -$10.60M.
- Edwards Lifesciences Corporation other comprehensive income (loss), derivatives qualifying as hedges, net of tax for the quarter ending 2017-06-30 was -$12.30M.
- Edwards Lifesciences Corporation other comprehensive income (loss), derivatives qualifying as hedges, net of tax for fiscal 2017 was -$30.60M, a 724.49% decline from fiscal 2016.
- Edwards Lifesciences Corporation other comprehensive income (loss), derivatives qualifying as hedges, net of tax for fiscal 2016 was $4.90M.
- Edwards Lifesciences Corporation other comprehensive income (loss), derivatives qualifying as hedges, net of tax for fiscal 2015 was -$20.50M, a 171.18% decline from fiscal 2014.
- Edwards Lifesciences Corporation other comprehensive income (loss), derivatives qualifying as hedges, net of tax for fiscal 2014 was $28.80M.
| Period end | Other Comprehensive Income (Loss), Derivatives Qualifying as Hedges, Net of Tax 3 month | Other Comprehensive Income (Loss), Derivatives Qualifying as Hedges, Net of Tax 6 month | Other Comprehensive Income (Loss), Derivatives Qualifying as Hedges, Net of Tax 9 month | Other Comprehensive Income (Loss), Derivatives Qualifying as Hedges, Net of Tax 12 month |
|---|---|---|---|---|
| 2018-03-31 | -$12.60M 10-Q · filed 2018-04-27 | -$14.00M derived: sum of 2 quarters · filed 2018-04-27 | -$24.60M derived: sum of 3 quarters · filed 2018-04-27 | -$36.90M derived: sum of 4 quarters · filed 2018-04-27 |
| 2017-12-31 | -$1.40M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-16 | -$12.00M derived: sum of 2 quarters · filed 2018-02-16 | -$24.30M derived: sum of 3 quarters · filed 2018-02-16 | -$30.60M 10-K · filed 2018-02-16 |
| 2017-09-30 | -$10.60M 10-Q · filed 2017-10-27 | -$22.90M derived: sum of 2 quarters · filed 2017-10-27 | -$29.20M 10-Q · filed 2017-10-27 | -$1.50M derived: sum of 4 quarters · filed 2018-04-27 |
| 2017-06-30 | -$12.30M 10-Q · filed 2017-07-28 | -$18.60M 10-Q · filed 2017-07-28 | $9.10M derived: sum of 3 quarters · filed 2018-04-27 | $7.10M derived: sum of 4 quarters · filed 2018-04-27 |
| 2017-03-31 | -$6.30M 10-Q · filed 2018-04-27 | $21.40M derived: sum of 2 quarters · filed 2018-04-27 | $19.40M derived: sum of 3 quarters · filed 2018-04-27 | $18.20M derived: sum of 4 quarters · filed 2018-04-27 |
| 2016-12-31 | $27.70M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-16 | $25.70M derived: sum of 2 quarters · filed 2018-02-16 | $24.50M derived: sum of 3 quarters · filed 2018-02-16 | $4.90M 10-K · filed 2018-02-16 |
| 2016-09-30 | -$2.00M 10-Q · filed 2017-10-27 | -$3.20M derived: sum of 2 quarters · filed 2017-10-27 | -$22.80M 10-Q · filed 2017-10-27 | -$28.50M derived: sum of 4 quarters · filed 2018-02-16 |
| 2016-06-30 | -$1.20M 10-Q · filed 2017-07-28 | -$20.80M 10-Q · filed 2017-07-28 | -$26.50M derived: sum of 3 quarters · filed 2018-02-16 | -$42.00M derived: sum of 4 quarters · filed 2018-02-16 |
| 2016-03-31 | -$19.60M 10-Q · filed 2017-04-28 | -$25.30M derived: sum of 2 quarters · filed 2018-02-16 | -$40.80M derived: sum of 3 quarters · filed 2018-02-16 | -$57.30M derived: sum of 4 quarters · filed 2018-02-16 |
| 2015-12-31 | -$5.70M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-16 | -$21.20M derived: sum of 2 quarters · filed 2018-02-16 | -$37.70M derived: sum of 3 quarters · filed 2018-02-16 | -$20.50M 10-K · filed 2018-02-16 |
| 2015-09-30 | -$15.50M 10-Q · filed 2016-10-28 | -$32.00M derived: sum of 2 quarters · filed 2016-10-28 | -$14.80M 10-Q · filed 2016-10-28 | |
| 2015-06-30 | -$16.50M 10-Q · filed 2016-07-29 | $700.00K 10-Q · filed 2016-07-29 | ||
| 2015-03-31 | $17.20M 10-Q · filed 2016-04-29 | |||
| 2014-12-31 | $28.80M 10-K · filed 2017-02-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| STERIS plc (STE) | Ireland | $20.343B | 25.49 |
| ZIMMER BIOMET HOLDINGS, INC. (ZBH) | United States | $17.103B | 20.66 |
| ALIGN TECHNOLOGY INC (ALGN) | United States | $10.346B | 29.06 |
| MSA Safety Inc (MSA) | United States | $7.023B | 21.47 |
| ESTABLISHMENT LABS HOLDINGS INC. (ESTA) | $1.954B | -65.76 | |
| Cadre Holdings, Inc. (CDRE) | United States | $1.123B | 33.88 |
| Enovis CORP (ENOV) | United States | $1.053B | -1.18 |
| Anteris Technologies Global Corp. (AVR) | United States | $0.746B | |
| Sanara MedTech Inc. (SMTI) | United States | $0.323B | -6.81 |
| Inogen Inc (INGN) | United States | $0.139B | -7.00 |